Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nova Pacific Metals Corp. | YQ10 | 9. oct 2024 | 0.22 | 0.00 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | 9. oct 2024 | 5.80 | +0.87 |
Novabay Pharmaceuticals | B9P | 9. oct 2024 | 2.80 | 0.00 |
Novacyt | NYZ | 9. oct 2024 | 0.66 | -1.65 |
Novagold Resources Inc. | NGR | 9. oct 2024 | 3.03 | +0.66 |
Novanta Inc. - | 1GSN | 9. oct 2024 | 158.00 | -0.63 |
Novartis AG | NOTA | 9. oct 2024 | 104.50 | +1.95 |
Novavax, Inc. | NVV1 | 9. oct 2024 | 11.77 | -1.14 |
Novem Group S.A. | NVM | 9. oct 2024 | 6.48 | +4.18 |
NOVINA S.A. E ZY 1,16 | T36 | 9. oct 2024 | 0.23 | -0.44 |
Novo Nordisk A/S | NOVA | 9. oct 2024 | 106.00 | -0.93 |
Novo Resources Corp | 1NOR | 9. oct 2024 | 0.06 | 0.00 |
Novo Resources Corp | 1NO | 9. oct 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | 9. oct 2024 | 13.15 | -0.08 |
NOVONIX ADR | GC30 | 9. oct 2024 | 1.87 | +10.65 |
Novonix Limited | GC3 | 9. oct 2024 | 0.50 | +17.26 |
NOVOTEK AB B SK-,25 | Z9D | 9. oct 2024 | 5.04 | 0.00 |
Novozymes AS | NZM | 9. oct 2024 | 62.00 | -1.59 |
Novozymes B | NZM2 | 9. oct 2024 | 62.24 | -1.11 |
Novra Technologies Inc. | 7CV | 9. oct 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | 9. oct 2024 | 0.34 | 0.00 |
NOW Inc. | 11N | 9. oct 2024 | 11.30 | -1.74 |
NP3 Fastigheter | N33 | 9. oct 2024 | 23.65 | -0.84 |
NPC Inc | 59N | 9. oct 2024 | 5.55 | -0.89 |
NRC Group | 8NR | 9. oct 2024 | 0.25 | -3.86 |
NRG Energy Inc. | NRA | 9. oct 2024 | 80.00 | -7.41 |
NRJ Group | NR8 | 9. oct 2024 | 7.62 | +0.26 |
NRW Holdings Limited | 3NR | 9. oct 2024 | 2.14 | +1.90 |
Ns United Kaiun Kaisha, Ltd. | 8WN | 9. oct 2024 | 28.20 | -0.70 |
NSE SA | 7YM | 9. oct 2024 | 28.70 | +0.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.